← Back to home
Comparison · Analytics

glyenzy vs ibdsim2

A side-by-side editorial comparison of glyenzy and ibdsim2 — release velocity, themes, recent moves, and the top alternatives to consider.

Shared themes:r-packages

glyenzy vs ibdsim2: at a glance

Featureglyenzyibdsim2
SectorAnalyticsAnalytics
Velocity score6.32.5
Sparks · 30d10
Top themesglycomics, biosynthesis, enzyme-inference, network-analysisstatistical-genetics, pedigree-analysis, simulation, r-packages
Last editorial update47m ago50m ago
WebsiteVisit →Visit →

What is glyenzy?

Glycan biosynthesis as a traceable enzyme graph, now including sulfation and gaps it can bridge.

glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.

Read the full glyenzy trajectory →

What is ibdsim2?

A pedigree IBD simulator that absorbed its own web app and now optimises for dense marker panels.

ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.

Read the full ibdsim2 trajectory →

glyenzy vs ibdsim2: editorial side-by-side

G
glyenzy
ANALYTICS
6.3

Glycan biosynthesis as a traceable enzyme graph, now including sulfation and gaps it can bridge.

◆ Current state

glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.

◆ Where it's heading

Two kinds of release alternate here. One is enzyme curation, a steady stream of rule corrections for the FUT, MAN1A and MGAT families and removals where an enzyme turned out to act only on glycolipids, which is the unglamorous accuracy work a rule-based inference engine lives on. The other is turning biosynthesis output into a first-class object: paths became networks, networks became typed with plotting support, and targets became a marked vertex attribute. The package moves in lockstep with its siblings, pinning glyrepr 0.13.0 and glymotif 0.17.0 as those refreshed their data and matching APIs, and the latest release already speaks glydraw 0.8.0's orientation values.

◆ Prediction

The paucimannose N-glycan support dropped in 0.7.0 is the obvious loose end, with users told to stay on 0.6.3, so a reinstated implementation is a plausible next move. Beyond that the virtual-step machinery is new enough that its heuristics, particularly the inferred step limits added in 0.8.1, should keep being tuned.

I
ibdsim2
ANALYTICS
2.5

A pedigree IBD simulator that absorbed its own web app and now optimises for dense marker panels.

◆ Current state

ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.

◆ Where it's heading

Two long-running threads. One is the app as a first-class part of the package, which has been getting input validation, dependency checks and plotting fixes release after release, treating a research GUI as software to be maintained rather than a demo. The other is numerical care: the built-in recombination map was rebuilt in 2.3.0 with better chromosome endpoints and a thinning algorithm that cut it from about 38,000 points to 14,000 without losing accuracy, and IBD segment merging has been made consistent across the realised-coefficient functions. The maintainer flags repeatedly that seeded results may differ across versions, which is the right disclosure for a simulator used in published analyses.

◆ Prediction

The recent work points at further speed on dense panels and continued hardening of app input handling, both of which have appeared in each of the last several releases. Nothing here signals a new modelling capability on the way.

Alternatives to glyenzy and ibdsim2

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either glyenzy or ibdsim2.

See all glyenzy alternatives → · See all ibdsim2 alternatives →

Recent activity from glyenzy and ibdsim2

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 11d agoibdsim2profileSimIBD() sped up for dense marker panels; segment merging fixed
  2. 14d agoglyenzyStep limits inferred from the target glycan; MGAT4 and MGAT5 rules updated
  3. 17d agoglyenzyBiosynthesis results become typed network objects with layered DAG plots
  4. 23d agoglyenzySulfotransferases become first-class, and unsupported steps can be bridged
  5. 1mo agoglyenzyCompatibility with glymotif 0.17.0 and later
  6. 1mo agoglyenzyEnzyme data refreshed against glyrepr 0.13.0 structure data
  7. 1mo agoglyenzyCorrected rules for the MAN1A1, MAN1A2 and MAN1C1 mannosidases
  8. 8mo agoibdsim2Segment-distribution merge argument, and function-valued parameters
  9. 1y agoibdsim2Built-in decode19 recombination map rebuilt, cutting 38k points to 14k
  10. 1y agoibdsim2Consistent IBD segment merging across the realised-coefficient functions
  11. 1y agoibdsim2Built-in pedigree labels revised; extra inbred examples added
  12. 1y agoibdsim2The Shiny front end moves into the package and gains X-chromosomal simulation

Frequently asked questions

What is the difference between glyenzy and ibdsim2?

Both compete on the same themes — r-packages — within Analytics. glyenzy is currently shipping more aggressively (velocity 6.3 vs 2.5), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is glyenzy better than ibdsim2?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. glyenzy is currently shipping more aggressively (velocity 6.3 vs 2.5), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to glyenzy?

Top glyenzy alternatives in Analytics are ranked by recent ship velocity. Browse the "glyenzy alternatives" section above for the current picks, or visit /alternatives/glyenzy for the full list with editorial commentary on each.

What are the best alternatives to ibdsim2?

Top ibdsim2 alternatives in Analytics are ranked by recent ship velocity. Browse the "ibdsim2 alternatives" section above for the current picks, or visit /alternatives/ibdsim2 for the full list with editorial commentary on each.